Back
Cullinan Therapeutics 10K Form
Sell
31
CGEM
Cullinan Therapeutics
Last Price:
11.76
Seasonality Move:
28.88%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive CGEM News And Ratings
See the #1 stock for the next 7 days that we like better than CGEM
CGEM Financial Statistics
Sales & Book Value
| Annual Sales: | $18.94M |
|---|---|
| Cash Flow: | $-34.14M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $10.80 |
| Price / Book: | 1.13 |
Profitability
| EPS (TTM): | -2.84000 |
|---|---|
| Net Income (TTM): | $-143.54M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Cullinan Therapeutics Earnings Forecast
Key Cullinan Therapeutics Financial Ratios
- Per Share Earnings over the last 8 years have been positive in 2 years.
Cullinan Therapeutics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | CGEM |
| Website: | cullinantherapeutics.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
CGEM Technical Analysis vs Fundamental Analysis
Sell
31
Cullinan Therapeutics (CGEM)
is a Sell
Is Cullinan Therapeutics a Buy or a Sell?
-
Cullinan Therapeutics stock is rated a Sell
The current Cullinan Therapeutics [CGEM] share price is $12.20. The Score for CGEM is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.